Company intelligence / Profile preview

Offenbach

Offenbach am Main, Hesse, Germany

Ownership: Private
Employees: ~500
Development stage: Other

Overview

BioSpring has nearly 30 years’ experience and is a global leader in manufacturing and analysis of therapeutic nucleic acids (RNA and DNA APIs), with expanding GMP capacity in Offenbach to support clinical and commercial supply especially for oligonucleotide-based drugs in oncology, neurodegeneration, and rare diseases

Therapeutic areas: OncologyNeurologyRare Diseases
Modalities: Antisense oligonucleotideRNA therapyDNA therapySmall interfering RNA
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Offenbach.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Offenbach.

Explore the full profile